Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-02-13Clinical Trial Update: A Study for Treatment of Superficial Bladder Cancer Using OGX-427 [Phase 1]
This clinical trial update covers a Phase 1 study of OGX-427 (apatorsen) for superficial bladder cancer, sponsored by Vancouver Coastal Heal…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Quality of Life and Symptom Management in Patients With Bladder Cancer
This completed clinical trial investigates quality of life and symptom management in patients with bladder cancer.
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Health-Related Quality of Life in Patients With Bladder Cancer
This entry provides an update on health-related quality of life outcomes from a completed bladder cancer trial (NCT00744744).
-
CLINICAL_TRIALS research · 2012-01-18Clinical Trial Update: Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker
A clinical trial evaluating whether tumor-specific T-cell immunity can serve as a prognostic marker in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum [Phase 2]
This is a completed Phase 2 clinical trial evaluating Genexol-PM in patients with advanced urothelial cancer (bladder or ureter cancer) prev…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Urine Cytology and Utility in Bladder Recurrence
This document is an update on a completed clinical trial evaluating the role of urine cytology in detecting bladder cancer recurrence. The s…
-
FDA approval · 2011-11-02FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for VALSTAR (valrubicin) from Endo USA, Inc., updating or expanding its labeling related to its …
-
EMA safety_alert · 2011-10-21European Medicines Agency clarifies opinion on pioglitazone and the risk of bladder cancer
The EMA clarifies its opinion regarding pioglitazone and the risk of bladder cancer, addressing safety concerns and regulatory stance.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases [Phase 3]
This completed Phase 3 trial evaluated USPIO-enhanced and diffusion-weighted MRI for detecting pelvic lymph node metastases in patients with…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial of preoperative intravesical electromotive mitomycin-C for primary non-muscle invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors [NA]
This update notes the completion of a University of Utah clinical trial evaluating exercise to improve mobility and reduce fatigue in older …
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer [Phase 3]
This Phase 3 trial compares sequential Bacillus Calmette-Guérin (BCG) followed by electromotive Mitomycin-C versus BCG alone in high-risk su…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Sorafenib in Urothelium Cancer of Bladder [Phase 2]
The Phase 2 trial of sorafenib for bladder cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer [EARLY_Phase 1]
Early-phase trial evaluating mitomycin C with hyperthermia and intravesical mitomycin C for recurrent bladder cancer has completed, with res…
-
FDA approval · 2011-08-26FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC, resulting in an updated regulatory status for the …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Cancer in Patients With Gabapentin (GPRD)
This clinical trial update reports cancer outcomes in patients treated with gabapentin, with results posted in 2011. It lists several cancer…
-
FDA approval · 2011-07-25FDA Approved: GEMCITABINE HYDROCHLORIDE — Original Application (Teyro Labs Private Limited)
The FDA approved an original ANDA for gemcitabine hydrochloride from Teyro Labs Private Limited, enabling its generic use.
-
EMA safety_alert · 2011-07-21European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer
EMA recommends new contraindications and warnings for pioglitazone to address a small increased risk of bladder cancer.
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer [Phase 3]
Phase 3 trial update evaluating hyperbaric oxygen therapy to treat long-term gastrointestinal adverse effects caused by pelvic cancer radiat…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer [Phase 2]
A Phase 2 clinical trial update for a peptide vaccine aimed at preventing recurrence in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer
This clinical trial update reports the completion of a study evaluating whether hematuria (microscopic or gross) can determine the presence …
-
CLINICAL_TRIALS research · 2011-06-08Clinical Trial Update: Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
This clinical trial update describes an observational study of subjects undergoing routine recurrence screening for bladder cancer, and note…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer [Phase 2]
This Phase 2 trial evaluated sunitinib as second-line therapy for locally advanced or metastatic transitional cell cancer of the bladder and…
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium [Phase 2]
This Phase 2 trial evaluated Sorafenib in regional or metastatic urothelial cancer and was terminated with results posted in 2011.
-
CLINICAL_TRIALS research · 2011-04-01Clinical Trial Update: Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer [Phase 2]
This Phase 2 trial compares standard surgery to minimal-access surgery for bladder cancer, with the study status currently unknown.